Home › Heart Attack › Texas › The Woodlands
Heart Attack clinical trials in The Woodlands, TX
3 studies for Heart Attack are looking for participants at sites in and around The Woodlands (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Renal Research of Montgomery County, The Woodlands
- DaVita Clinical Research North Houston, Shenandoah · 3 mi away
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- Northwest Houston Clinical Research PLLC, Tomball · 9 mi away
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- Tcr Institute Llc, Kingwood · 20 mi away
About Heart Attack
A heart attack happens when the blood flow to the heart gets blocked. It causes heart damage and is a medical emergency. Know the symptoms and when to call 911.
More about Heart Attack on MedlinePlus
Heart Attack trials in other cities
- Rochester, MN6 studies
- Dallas, TX6 studies
- New York City, NY6 studies
- Boston, MA5 studies
- Nashville, TN4 studies
- Detroit, MI4 studies
- Knoxville, TN4 studies
- Houston, TX4 studies
- Hartford, CT4 studies
- Boca Raton, FL4 studies
- Los Angeles, CA4 studies
- Raleigh, NC3 studies
Other studies in The Woodlands
- Non-Small Cell Lung Cancer15 studies
- Obesity12 studies
- Breast Cancer10 studies
- Overweight10 studies
- Metastatic Cancer9 studies
- Cardiovascular Disease9 studies
- Macular Degeneration9 studies
- Heart Failure7 studies
- Lung Cancer7 studies
- Type 2 Diabetes7 studies
- Prostate Cancer6 studies
- Atherosclerosis6 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.